[Effect of low-frequency ultrasound on non-clostridial anaerobic microflora]. 1987

V K Gostishchev, and S S Oganesian, and N A Tarverdian

Under analysis is an experience with the treatment of 78 patients with various purulent diseases of soft tissues caused by non-clostridial anaerobic microorganisms in a pure form or in combination with aerobic microflora treated with using low frequency ultrasound. The ultrasound was found not to alter the antimicrobial properties of antibacterial drugs. The degree of bacterial dissemination of the wounds was reliably lower. By the end of the treatment (on the 10-11th days) no growth of microflora was found in 25.7% of the examined patients. The sensitivity of anaerobic microorganisms to antibiotics not only became higher in the process of treatment with ultrasound but there appeared strains sensitive to other antibiotics.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001420 Bacteria, Aerobic Bacteria which require oxygen in order to grow and survive. Aerobic Bacteria
D001421 Bacteria, Anaerobic Bacteria that can survive and grow in the complete, or nearly complete absence of oxygen. Anaerobic Bacteria

Related Publications

V K Gostishchev, and S S Oganesian, and N A Tarverdian
April 1985, Khirurgiia,
V K Gostishchev, and S S Oganesian, and N A Tarverdian
April 1982, Khirurgiia,
V K Gostishchev, and S S Oganesian, and N A Tarverdian
January 1990, Sovetskaia meditsina,
V K Gostishchev, and S S Oganesian, and N A Tarverdian
June 1989, Khirurgiia,
V K Gostishchev, and S S Oganesian, and N A Tarverdian
January 2008, Khirurgiia,
V K Gostishchev, and S S Oganesian, and N A Tarverdian
November 1978, Journal of the Indian Medical Association,
V K Gostishchev, and S S Oganesian, and N A Tarverdian
January 1987, Sovetskaia meditsina,
V K Gostishchev, and S S Oganesian, and N A Tarverdian
September 1988, Khirurgiia,
V K Gostishchev, and S S Oganesian, and N A Tarverdian
January 1983, Grudnaia khirurgiia (Moscow, Russia),
V K Gostishchev, and S S Oganesian, and N A Tarverdian
August 1982, Khirurgiia,
Copied contents to your clipboard!